VentorLux1
Biotechnology Research
2 employees
- Employees
- 2
- Contacts
- 2
- Emails
- 2
- Phones
- 2
VentorLux1 Overview
- Website
- ventorlux1.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2018
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About VentorLux1
VentorLux has patent-pending game changing anti-microbial germicidal technology with the capacity to reduce, destroy and inoculate airborne pathogens such as SARs-CoV-2, the cause of the disease COVID-19, within MINUTES of use. Soulis Air Defense is a medical counter-measure and new form of Personal Protective Equipment (PPE) in the fight against the invisible enemies that cause sick-building syndrome, healthcare acquired infrections (HAIs) and viral infections and diseases like COVID-19, SARs, MRSA, c.Diff, e.Coli, molds and Influenza like H1N1.
VentorLux1 Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 2
- 100.0% coverage
VentorLux1 Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Vincent Sessoms, Msph | Financial Strategist - Business | Nashville, Tennessee, United States |
Email
Phone
|
| Larry Laymon | Principal, Co-founder & CEO | Franklin, Tennessee, United States |
Email
Phone
|